Literature DB >> 15019063

Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

S Sethia1, E Squillante.   

Abstract

This study compares the physicochemical properties of carbamazepine (CBZ) solid dispersions prepared by either a conventional solvent evaporation versus a supercritical fluid process. Solid dispersions of carbamazepine in polyvinylpyrrolidone (PVP) K30 with either Gelucire 44/14 or Vitamin E TPGS, NF (d-alpha-tocopheryl polyethylene glycol 1000 succinate) were prepared and characterized by intrinsic dissolution, differential scanning calorimetry, powder X-ray diffraction and Fourier transform infrared spectroscopy. CBZ/PVP K30 and CBZ/PVP K30/TPGS solid dispersions showed increased dissolution rate. The best intrinsic dissolution rate (IDR) was obtained for supercritically processed CBZ/PVP K30 that was four-fold higher than pure CBZ. Thermograms of various solid dispersions did not show the melting peak of CBZ, indicating that CBZ was in amorphous form inside the carrier system. This was further confirmed by X-ray diffraction studies. Infrared spectroscopic studies showed interaction between CBZ and PVP K30 in solid dispersions. The amorphous state of CBZ coupled with presence of interaction between drug and PVP K30 suggests fewer, if any, stability problems. Because the supercritical-based process produced solid dispersions with IDR better than conventional solid dispersions augmented with amphiphilic carriers, stability issues associated with lipid carriers do not apply, which, in turn, implies easier scale up under current Good Manufacturing Practice for this technique.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019063     DOI: 10.1016/j.ijpharm.2003.11.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  67 in total

1.  Process Analytical Quality Control of Tailored Drug Release Formulation Prepared via Hot-Melt Extrusion Technology.

Authors:  Jun-Bom Park; Beom-Jin Lee; Chin-Yang Kang; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2017-01-25       Impact factor: 3.981

2.  Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.

Authors:  Bhaskar Chauhan; Shyam Shimpi; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

3.  Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.

Authors:  Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Ahmed S Zidan
Journal:  AAPS PharmSciTech       Date:  2006-06-16       Impact factor: 3.246

4.  Dissolution improvement of high drug-loaded solid dispersion.

Authors:  Siriporn Okonogi; Satit Puttipipatkhachorn
Journal:  AAPS PharmSciTech       Date:  2006-06-02       Impact factor: 3.246

5.  Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L.

Authors:  Yan Xie; Guowen Li; Xiurong Yuan; Zhenzhen Cai; Rong Rong
Journal:  AAPS PharmSciTech       Date:  2009-05-19       Impact factor: 3.246

6.  In vitro, ex vivo and in silico mechanistic elucidation of the performance of an optimized porosity-controlled multi-elemental transbuccal system.

Authors:  Oluwatoyin A Adeleke; Yahya E Choonara; Lisa C du Toit; Pradeep Kumar; Viness Pillay
Journal:  Pharm Res       Date:  2015-01-29       Impact factor: 4.200

7.  Inclusion of Digestible Surfactants in Solid SMEDDS Formulation Removes Lag Time and Influences the Formation of Structured Particles During Digestion.

Authors:  Kapilkumar Vithani; Adrian Hawley; Vincent Jannin; Colin Pouton; Ben J Boyd
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

8.  Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.

Authors:  Saad M Alshahrani; Wenli Lu; Jun-Bom Park; Joseph T Morott; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-01-08       Impact factor: 3.246

9.  Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies.

Authors:  Yu-Tsai Yang; Anthony J Di Pasqua; Yong Zhang; Katsuhiko Sueda; Michael Jay
Journal:  Pharm Dev Technol       Date:  2013-09-19       Impact factor: 3.133

10.  Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.

Authors:  Ying Li; Da-Jian Yang; Shi-Lin Chen; Si-Bao Chen; Albert Sun-Chi Chan
Journal:  Pharm Res       Date:  2007-09-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.